Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can occur after treating diabetic ketoacidosis, especially with rapid weight loss and high soft drink intake.

Hair loss from weight-loss treatments is usually temporary and reversible.

Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.

Albendazole likely caused temporary hair loss in a 25-year-old woman.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

Severe COVID-19 increases the risk of hair loss.

Se necesita más investigación para entender mejor la pérdida de cabello en mujeres en Colombia.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

Managing telogen effluvium is challenging due to limited scientific evidence.

A woman had temporary hair loss after a facelift, which improved on its own within a year.

A rare case of a man having both frontal fibrosing alopecia and vitiligo was reported.

Females, especially over 40, are more likely to experience temporary hair loss after hair restoration surgery.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Women with telogen effluvium have an imbalance in thiol-disulphide, suggesting oxidative stress may contribute to hair loss.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

High TNF-α levels may increase hair loss risk after PRP therapy.

A man regrew hair after using a 2% fluorouracil treatment on his scalp.

A 7-year-old girl with non-scarring alopecia will have hair follicle transplantation to improve her quality of life.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Serum ferritin can help diagnose Telogen Effluvium.

Alopecia triangular temporal is a rare condition with unclear causes and treatment, but trichoscopy helps in diagnosis.

Hair loss (telogen effluvium) happens before male pattern baldness.

Red stripes on nails and hair loss may occur after COVID-19.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.